13F

Stock

Quince Therapeutics, Inc.

QNCX · held by 1 managers

Reported value

$30

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$13

Price effect on 1 books still in the name

Largest holder

$30

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC23$30−$13Cut−$157

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.